A detailed history of Camarda Financial Advisors, LLC transactions in Stryker Corp stock. As of the latest transaction made, Camarda Financial Advisors, LLC holds 6,470 shares of SYK stock, worth $2.33 Million. This represents 1.02% of its overall portfolio holdings.

Number of Shares
6,470
Previous 5,779 11.96%
Holding current value
$2.33 Million
Previous $2.29 Million 4.59%
% of portfolio
1.02%
Previous 1.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

BUY
$368.57 - $403.53 $254,681 - $278,839
691 Added 11.96%
6,470 $2.39 Million
Q2 2025

Aug 14, 2025

BUY
$337.37 - $395.63 $337 - $395
1 Added 0.02%
5,779 $2.29 Million
Q1 2025

May 15, 2025

SELL
$355.18 - $399.9 $2,486 - $2,799
-7 Reduced 0.12%
5,778 $2.15 Million
Q4 2024

Feb 14, 2025

BUY
$345.14 - $392.15 $2 Million - $2.27 Million
5,785 New
5,785 $2.08 Million

Others Institutions Holding SYK

About STRYKER CORP


  • Ticker SYK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 378,320,992
  • Market Cap $136B
  • Description
  • Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products c...
More about SYK
Track This Portfolio

Track Camarda Financial Advisors, LLC Portfolio

Follow Camarda Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Camarda Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Camarda Financial Advisors, LLC with notifications on news.